Ray Lockard
Chief Tech/Sci/R&D Officer at TSCAN THERAPEUTICS, INC.
Profile
Ray Lockard is currently working as the Senior VP-Technical Operations & Quality at TScan Therapeutics, Inc. Prior to this, he worked as the Executive Director-CMC, QA & External Quality at Ultragenyx Pharmaceutical, Inc. from 2020 to 2021, and as the Head-Site Quality at Novartis Gene Therapies, Inc. from 2019 to 2020.
Mr. Lockard completed his undergraduate degree at Hampden-Sydney College and holds an MBA from Kenan-Flagler Business School.
Ray Lockard active positions
| Companies | Position | Start |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 06/04/2023 |
Former positions of Ray Lockard
| Companies | Position | End |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/12/2021 |
| AVEXIS INC | Corporate Officer/Principal | 01/10/2020 |
Training of Ray Lockard
| Hampden-Sydney College | Undergraduate Degree |
| Kenan-Flagler Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| TSCAN THERAPEUTICS, INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| Private companies | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Stock Market
- Insiders
- Ray Lockard
